Gene mutation combination serving as marker of MRKH syndrome and application of gene mutation combination

A syndrome and diagnostic marker technology, applied in the fields of biotechnology and medical diagnosis, can solve problems such as difficulty in collecting case samples, loss of protein function, and infertility of patients, so as to reduce birth rate, incidence rate, and strong pathogenicity Effect

Active Publication Date: 2021-04-23
PEKING UNION MEDICAL COLLEGE HOSPITAL CHINESE ACAD OF MEDICAL SCI
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, MRKH syndrome is a rare disease. Due to the small number of case samples, difficulty in collecting case samples, and the infertility of patients, families with good research value are very rare, and there is still a lack of possible pathogenic gene mutations for MRKH syndrome. Based on this, the present invention found the following mutation sites on the PAX8 gene for the first time by performing whole-exome sequencing analysis on 442 MRKH patients and 941 female controls: c.236C>G, c.156_157dupCG , c.25+1G>T, c.195delC, c.322C>T and c.542C>T. It has been verified that the above mutation sites will lead to the loss of the function of the protein corresponding to PAX8, which will lead to MRKH syndrome

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gene mutation combination serving as marker of MRKH syndrome and application of gene mutation combination
  • Gene mutation combination serving as marker of MRKH syndrome and application of gene mutation combination
  • Gene mutation combination serving as marker of MRKH syndrome and application of gene mutation combination

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0063] The present invention will be further elaborated below in conjunction with specific examples, which are only used to explain the present invention, and should not be construed as limiting the present invention. Those of ordinary skill in the art can understand that: without departing from the principle and purpose of the present invention, various changes, modifications, replacements and modifications can be made to these embodiments, and the scope of the present invention is defined by the claims and their equivalents . For the experimental methods that do not indicate specific conditions in the following examples, the detection is usually carried out according to conventional conditions or according to the conditions suggested by the manufacturer.

[0064] Identification and verification of the mutation site of the pathogenic gene of the embodiment

[0065] 1. Research population

[0066] Research cohort: the present invention has recruited 442 MRKH syndrome patient...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a gene mutation combination serving as a marker of the MRKH syndrome and application of the gene mutation combination, and relates to the field of biotechnology and medical diagnosis. The gene mutation combination is a group of pathogenic gene mutation sites related to the MRKH syndrome. According to the research of the invention, by whole exome sequencing, the following mutation sites on a gene PAX8 of a patient with the rare MRKH syndrome are found in the world for the first time: c.236C> G, c.156_157dupCG, c.25+1G> T, c.195delC, c.322C> T and c.542C> T; and experimental verification shows that the mutant gene PAX8 carrying the mutation sites can be used as the diagnosis marker of the MRKH syndrome, is used for diagnosing whether the patient suffers from the MRKH syndrome or not and carrying out pre-pregnancy early warning, and provides a brand-new thought for researching the pathogenesis of the MRKH syndrome.

Description

technical field [0001] The invention belongs to the field of biotechnology and medical diagnosis, and in particular relates to a group of pathogenic gene mutation sites related to MRKH syndrome, and the preparation of reagents or reagents for the diagnosis of MRKH syndrome by the pathogenic genes carrying these gene mutation sites application in the box. Background technique [0002] MRKH (Mayer-Rokitansky-Küster-Hauser) syndrome, also known as congenital absence of the vagina, is a structural defect of the female reproductive system. The clinical features of the patient are complete absence of the uterus and upper 2 / 3 segments For example (even if it is the primordial uterus), the reproductive and endocrine functions of the ovaries are normal, the development of secondary sexual characteristics is normal, the karyotype is 46, XX, and the incidence rate is about 1 / 4500-5000 newborn girls. MRKH syndrome can be divided into two types according to whether it is combined with a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6883G01N33/68C12N15/11C07K16/18
CPCC12Q1/6883G01N33/6893G01N33/6854C07K16/18C12Q2600/156G01N2800/36
Inventor 朱兰陈娜吴南赵森田维杰
Owner PEKING UNION MEDICAL COLLEGE HOSPITAL CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products